SGHT - Sight Sciences Inc logo

Sight Sciences Inc

SGHT

Sight Sciences develops and sells surgical and nonsurgical devices for glaucoma and dry eye treatment. Its products include OMNI, SION, and TearCare systems, serving hospitals and eyecare professionals in the U.S. to improve patient outcomes.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$355today

Score Overview

1 Year
Score
Net Growth22.56%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth7.77%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.4
Net Growth52.74%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth70.31%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth52.74%
Net Trend80%
Net Income Consistency
Rev Growth70.31%
Rev Trend60%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Sight Sciences Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. SGHT does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 9.09โ€”
1 Year2025-10-22
$ 5.1377.19%
5 Years2021-10-22
$ 25.64-64.55%
All Time2021-07-15
$ 33.50-72.87%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 83M-$ 29M$ 79M
2025$ 77M-$ 38M$ 91M
2024$ 79M-$ 51M$ 120M
2023$ 81M-$ 55M$ 138M
2022$ 71M-$ 86M$ 185M
IPO2021$ 48M-$ 62M$ 260M
SGHT - Sight Sciences Inc logo

Sight Sciences Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 48M to $ 77M and net income went from -$ 62M to -$ 38M. Revenue increased in 60% of the years measured; net income in 80%.

Sight Sciences Inc currently holds a 5-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.

Membership

Explore SGHT with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies